The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis
Authors
Keywords
Tobacco use disorder, Nicotine dependence, Schizophrenia, Bipolar disorder, Major depressive disorder, Prevalence, Treatment, Psychiatry, Neuroscience, Smoking cessation
Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 132, Issue -, Pages 289-303
Publisher
Elsevier BV
Online
2021-11-25
DOI
10.1016/j.neubiorev.2021.11.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders
- (2020) Joseph Firth et al. World Psychiatry
- Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES
- (2020) A. Eden Evins et al. PSYCHIATRIC SERVICES
- Lung cancer incidence in patients with schizophrenia: meta-analysis
- (2019) Chuanjun Zhuo et al. BRITISH JOURNAL OF PSYCHIATRY
- Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis
- (2018) Michele Fornaro et al. BIPOLAR DISORDERS
- Association between depression and smoking: A global perspective from 48 low- and middle-income countries
- (2018) Brendon Stubbs et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
- (2016) Robert M Anthenelli et al. LANCET
- Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial
- (2016) Arthur L. Brody et al. NICOTINE & TOBACCO RESEARCH
- Assessment of cigarette smoking status with respect to symptomatic manifestation in first-episode schizophrenia patients
- (2015) Błażej Misiak et al. COMPREHENSIVE PSYCHIATRY
- Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
- (2014) Douglas Boggs et al. CURRENT PHARMACEUTICAL DESIGN
- Risks of all-cause and suicide mortality in mental disorders: a meta-review
- (2014) Edward Chesney et al. World Psychiatry
- Shared genetic factors influence risk for bipolar disorder and alcohol use disorders
- (2013) N. Carmiol et al. EUROPEAN PSYCHIATRY
- Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia
- (2013) Zsuzsa Szombathyne Meszaros et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates
- (2013) Shaul Lev-Ran et al. PSYCHIATRY RESEARCH
- Prevalence and correlates of heavy smoking and nicotine dependence in adolescents with bipolar and cannabis use disorders
- (2013) Jaimee L. Heffner et al. PSYCHIATRY RESEARCH
- Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
- (2013) Felice Iasevoli et al. Neuropsychiatric Disease and Treatment
- Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder?
- (2012) Joseph M. Cerimele et al. JOURNAL OF CLINICAL PSYCHIATRY
- The hardening hypothesis: Is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary
- (2011) John R. Hughes DRUG AND ALCOHOL DEPENDENCE
- Empirically derived subgroups of bipolar I patients with different comorbidity patterns of anxiety and substance use disorders in Han Chinese population
- (2011) Han-Chieh Tsai et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
- (2011) Jennifer W. Tidey et al. PSYCHOPHARMACOLOGY
- Why do patients with schizophrenia smoke?
- (2010) Georg Winterer CURRENT OPINION IN PSYCHIATRY
- Cocaine and amphetamine regulated transcript (CART) gene in the comorbidity of schizophrenia with alcohol use disorders and nicotine dependence
- (2010) Amaya Busto et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Time to Rehospitalization in Patients With Major Depressive Disorder Taking Venlafaxine or Fluoxetine
- (2009) Ching-Hua Lin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nicotine dependence and psychiatric disorders among young males in Singapore
- (2009) Mythily Subramaniam et al. NICOTINE & TOBACCO RESEARCH
- Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
- (2008) D. Ziedonis et al. NICOTINE & TOBACCO RESEARCH
- Associations between depression subtypes and substance use disorders
- (2008) Adam M. Leventhal et al. PSYCHIATRY RESEARCH
- Nicotine dependence and mental disorders among adults in the USA: evaluating the role of the mode of administration
- (2008) R. D. Goodwin et al. PSYCHOLOGICAL MEDICINE
- A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
- (2007) Tony P. George et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started